Position in ABBV
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$5,376,791
+$819,724 QoQ
Shares Held
21,367
+2.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.92%
of 13F equity value
Holder Rank
#1,263
of 4,152 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WEALTH ALLIANCE, LLC holds $31,462,048 across 11 Drug Manufacturers - General names. ABBV ranks #2 (17.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
7,574 | $9,084,483 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
21,367 | $5,376,791 | |
| 3 | AMGN |
Amgen Inc
|
11,201 | $4,056,106 | |
| 4 | JNJ |
Johnson & Johnson
|
14,755 | $3,747,327 | |
| 5 | MRK |
Merck & Co., Inc.
|
21,770 | $2,797,445 | |
| 6 | PFE |
Pfizer Inc
|
93,388 | $2,248,783 | |
| 7 | AZN |
Astrazeneca PLC
|
8,277 | $1,569,484 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
18,651 | $1,074,670 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,376,791 | 21,367 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $4,557,067 | 20,953 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $5,012,842 | 21,939 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $5,459,481 | 23,579 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $4,870,297 | 26,238 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $5,014,861 | 23,935 | Shares | Defined | 2025-05-05 | |
| 2024-12-31 | $4,028,814 | 22,672 | Shares | Defined | 2025-02-03 | |
| 2024-09-30 | $4,323,429 | 21,893 | Shares | Defined | 2024-11-04 | |
| 2024-06-30 | $3,742,051 | 21,817 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $3,985,076 | 21,884 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $3,987,533 | 25,731 | Shares | Defined | 2024-01-30 | |
| 2023-09-30 | $3,523,778 | 23,640 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $3,062,682 | 22,732 | Shares | Defined | 2023-08-02 | |
| 2023-03-31 | $3,847,988 | 24,145 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $3,972,373 | 24,580 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $3,191,781 | 23,782 | Shares | Defined | 2022-11-14 | |
| 2022-03-31 | $3,823,039 | 23,583 | Shares | Defined | 2022-05-10 | |
| 2021-12-31 | $3,033,230 | 22,402 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,384,574 | 22,106 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $2,424,913 | 21,528 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $2,130,635 | 19,688 | Shares | Defined | 2021-05-18 | |
| 2020-12-31 | $2,046,136 | 19,096 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $1,559,890 | 17,809 | Shares | Defined | 2020-12-01 | |
| 2020-06-30 | $1,741,811 | 17,741 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $1,004,641 | 13,186 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||